Who is the Manufacturer of Orgovyx?
•
2 min read
Approved by the FDA in December 2020, Orgovyx (relugolix) marked a significant milestone as the first oral gonadotropin-releasing hormone (GnRH) receptor antagonist for advanced prostate cancer. The initial manufacturer and commercializing partner for Orgovyx was Myovant Sciences, Inc., working in collaboration with Pfizer, Inc.
